Jennifer K. Loo

1.9k total citations
13 papers, 545 citations indexed

About

Jennifer K. Loo is a scholar working on Gastroenterology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jennifer K. Loo has authored 13 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gastroenterology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jennifer K. Loo's work include Gastrointestinal Tumor Research and Treatment (11 papers), Immune Cell Function and Interaction (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Jennifer K. Loo is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (11 papers), Immune Cell Function and Interaction (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Jennifer K. Loo collaborates with scholars based in United States, France and Canada. Jennifer K. Loo's co-authors include Ronald P. DeMatteo, Jennifer Q. Zhang, Ferdinand Rossi, Shan Zeng, Cristina R. Antonescu, Adrian M. Seifert, Benjamin D. Medina, Joanna H. Maltbaek, Nesteene J. Param and Gerardo A. Vitiello and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Jennifer K. Loo

13 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer K. Loo United States 11 221 220 197 152 104 13 545
Hiroyuki Hiraki Japan 10 171 0.8× 80 0.4× 97 0.5× 47 0.3× 109 1.0× 15 372
Jacek Sygut Poland 13 175 0.8× 136 0.6× 142 0.7× 33 0.2× 68 0.7× 45 496
Tambudzai Shamu United States 6 293 1.3× 141 0.6× 74 0.4× 28 0.2× 246 2.4× 7 506
Mercedes M. Condy United States 8 328 1.5× 61 0.3× 252 1.3× 40 0.3× 105 1.0× 15 456
Jan Åhlén Sweden 10 171 0.8× 90 0.4× 75 0.4× 23 0.2× 100 1.0× 20 352
Maria Stefania Lagonigro Italy 10 382 1.7× 319 1.4× 65 0.3× 32 0.2× 112 1.1× 13 679
Céline Brulard France 11 289 1.3× 73 0.3× 139 0.7× 21 0.1× 165 1.6× 17 514
Craig A. Rumpel United States 8 132 0.6× 132 0.6× 125 0.6× 23 0.2× 124 1.2× 8 425
Francesca Franzi Italy 12 152 0.7× 27 0.1× 410 2.1× 157 1.0× 101 1.0× 23 700
Mee‐Hye Oh South Korea 13 146 0.7× 34 0.2× 154 0.8× 37 0.2× 222 2.1× 44 491

Countries citing papers authored by Jennifer K. Loo

Since Specialization
Citations

This map shows the geographic impact of Jennifer K. Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer K. Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer K. Loo more than expected).

Fields of papers citing papers by Jennifer K. Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer K. Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer K. Loo. The network helps show where Jennifer K. Loo may publish in the future.

Co-authorship network of co-authors of Jennifer K. Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer K. Loo. A scholar is included among the top collaborators of Jennifer K. Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer K. Loo. Jennifer K. Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rossi, Ferdinando, Jennifer K. Loo, Nesteene J. Param, et al.. (2023). Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumor. Oncogene. 42(34). 2578–2588. 2 indexed citations
2.
Zhang, Jennifer Q., Benedikt Bosbach, Jennifer K. Loo, et al.. (2020). The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor. Oncogene. 39(49). 7153–7165. 9 indexed citations
3.
Medina, Benjamin D., Mengyuan Liu, Gerardo A. Vitiello, et al.. (2019). Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity. The Journal of Experimental Medicine. 216(6). 1359–1376. 22 indexed citations
4.
Santamaria‐Barria, Juan A., Shan Zeng, Jonathan B. Greer, et al.. (2019). Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells. PLoS ONE. 14(5). e0216275–e0216275. 12 indexed citations
5.
Vitiello, Gerardo A., Timothy G. Bowler, Mengyuan Liu, et al.. (2019). Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor. Journal of Clinical Investigation. 129(5). 1863–1877. 52 indexed citations
6.
Zhang, Jennifer Q., Shan Zeng, Gerardo A. Vitiello, et al.. (2018). Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunology Research. 6(4). 434–447. 48 indexed citations
7.
Vitiello, Gerardo A., Shan Zeng, Timothy G. Bowler, et al.. (2017). Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Clinical Cancer Research. 24(4). 972–984. 45 indexed citations
8.
Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 16(9). 1954–1966. 31 indexed citations
9.
Bosbach, Benedikt, Ferdinand Rossi, Jennifer K. Loo, et al.. (2017). Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor. Proceedings of the National Academy of Sciences. 114(40). E8448–E8457. 37 indexed citations
10.
Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor. Oncotarget. 8(69). 114195–114209. 24 indexed citations
11.
D’Angelo, Sandra P., Alexander N. Shoushtari, Mary Louise Keohan, et al.. (2016). Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clinical Cancer Research. 23(12). 2972–2980. 98 indexed citations
12.
Seifert, Adrian M., Shan Zeng, Jennifer Q. Zhang, et al.. (2016). PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 23(2). 454–465. 117 indexed citations
13.
Conway, Tenley M., et al.. (2008). Developing ecological footprint scenarios on university campuses. International Journal of Sustainability in Higher Education. 9(1). 4–20. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026